NEW YORK (GenomeWeb News) – Thermo Fisher Scientific and the National University of Singapore today announced the signing of a memorandum of understanding to develop a strategic alliance to increase advance basic and applied research in Singapore.

The agreement covers the life sciences, healthcare, and applied markets, and includes cancer and diagnostics. Thermo Fisher and NUS will develop analytical technologies, reagents, instruments, and software, they said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

ScienceInsider reports that a new security policy at the US Food and Drug Administration may prevent foreign nationals from working there.

WBUR in Boston looks into Orig3n's genetic fitness assessments to find more research is needed.

Cleveland.com reports that getting a DNA profile removed from a law enforcement database can be tricky.

In PNAS this week: de novo mutations contribute to non-syndromic craniosynostosis, fungal tree of life, and more.